These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

159 related items for PubMed ID: 2088187

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. In vitro and in vivo antibacterial activities of T-3761, a new quinolone derivative.
    Fukuoka Y, Ikeda Y, Yamashiro Y, Takahata M, Todo Y, Narita H.
    Antimicrob Agents Chemother; 1993 Mar; 37(3):384-92. PubMed ID: 8460909
    [Abstract] [Full Text] [Related]

  • 26. In vitro activity of AT-4140 against clinical bacterial isolates.
    Kojima T, Inoue M, Mitsuhashi S.
    Antimicrob Agents Chemother; 1989 Nov; 33(11):1980-8. PubMed ID: 2558617
    [Abstract] [Full Text] [Related]

  • 27. Ciprofloxacin, a quinolone carboxylic acid compound active against aerobic and anaerobic bacteria.
    Chin NX, Neu HC.
    Antimicrob Agents Chemother; 1984 Mar; 25(3):319-26. PubMed ID: 6232895
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. In vitro and in vivo activities of a new quinolone, WIN 57273, possessing potent activity against gram-positive bacteria.
    Sedlock DM, Dobson RA, Deuel DM, Lesher GY, Rake JB.
    Antimicrob Agents Chemother; 1990 Apr; 34(4):568-75. PubMed ID: 2344163
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Comparative in vitro activity of lomefloxacin, a new difluoroquinolone.
    Clarke AM, Zemcov SJ.
    Eur J Clin Microbiol Infect Dis; 1989 Feb; 8(2):164-8. PubMed ID: 2498101
    [Abstract] [Full Text] [Related]

  • 33. In vitro antibacterial activity of a new quinolone, NM394.
    Ozaki M, Matsuda M, Tomii Y, Kimura K, Kazuno K, Kitano M, Kise M, Shibata K, Otsuki M, Nishino T.
    Antimicrob Agents Chemother; 1991 Dec; 35(12):2490-5. PubMed ID: 1667251
    [Abstract] [Full Text] [Related]

  • 34. Lomefloxacin, a new difluoroquinolone: in vitro activity against gram-positive and gram-negative bacteria.
    Hoban D, Grabowski M, Koss J, Weselowski V.
    Diagn Microbiol Infect Dis; 1989 Dec; 12(3 Suppl):77S-82S. PubMed ID: 2791502
    [Abstract] [Full Text] [Related]

  • 35. In vitro activity of lomefloxacin (NY-198 or SC 47111).
    Shah PM, Müller S, Kipp J, Stille W.
    Diagn Microbiol Infect Dis; 1989 Dec; 12(3 Suppl):97S-101S. PubMed ID: 2791506
    [Abstract] [Full Text] [Related]

  • 36. In-vitro activity of PD 117558, a new quinolone against bacterial isolates from cancer patients.
    Rolston KV, LeBlanc B, Gooch G, Ho DH, Bodey GP.
    J Antimicrob Chemother; 1989 Mar; 23(3):363-71. PubMed ID: 2732120
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.